ArticleMolecular neurobiology2018
Cannabis Users Show Enhanced Expression of CB
Abstract read
In one paragraph
Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 44 citations in OpenAlex.
- Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022Trial
- The Potential of Cannabidiol for the Treatment of Psychosis: Endocannabinoid Regulation of Serotonergic Neurotransmission via Serotonin 5-HT1A/2A Receptors.Neurochemical research · 2026Review
- Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care.Translational psychiatry · 2026Review
- Mechanistic and therapeutic insights into class A GPCR dimers in neuropsychiatric disorders.npj drug discovery · 2026Review
- Cystic fibrosis alters the structure of the olfactory epithelium and the expression of olfactory receptors affecting odor perception.Science advances · 2025Article
- Design of Small Non-Peptidic Ligands That Alter Heteromerization between Cannabinoid CBJournal of medicinal chemistry · 2025Article
- Distinct patterns of cell adhesion, migration, and morphology in olfactory neuroepithelium cells of bipolar disorder patients.Molecular medicine (Cambridge, Mass.) · 2024Article
- Altered PLCβ/IPBiomedicines · 2024Article
- Early biomarkers in the presymptomatic phase of cognitive impairment: changes in the endocannabinoidome and serotonergic pathways in Alzheimer's-prone mice after mTBI.Acta neuropathologica communications · 2024Article
- Allosteric Modulators of Serotonin Receptors: A Medicinal Chemistry Survey.Pharmaceuticals (Basel, Switzerland) · 2024Review
- Potential of olfactory neuroepithelial cells as a model to study schizophrenia: A focus on GPCRs (Review).International journal of molecular medicine · 2024Review
- Cognitive Alterations in Addictive Disorders: A Translational Approach.Biomedicines · 2023Review
- Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients.Addiction biology · 2022Article
- Endocannabinoid-mediated neuromodulation in the main olfactory bulb at the interface of environmental stimuli and central neural processing.The European journal of neuroscience · 2022Review
- Class A and C GPCR Dimers in Neurodegenerative Diseases.Current neuropharmacology · 2022Review
- Probing GPCR Dimerization Using Peptides.Frontiers in endocrinology · 2022Review
- The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids.Journal of the National Cancer Institute. Monographs · 2021Article
- Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects.Journal of medicinal chemistry · 2021Article
- Olfactory Neuroepithelium Cells from Cannabis Users Display Alterations to the Cytoskeleton and to Markers of Adhesion, Proliferation and Apoptosis.Molecular neurobiology · 2021Article
- Which came first: Cannabis use or deficits in impulse control?Progress in neuro-psychopharmacology & biological psychiatry · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 7 institutions in 4 countries.
Liliana GalindoNeuropsychiatry and Addictions Institute (INAD) of Parc de Salut Mar, Centro de Investigación Biomédica En Red de Salud Mental G21, Mental Health Research Group, IMIM-Hospital del Mar Research Institute, Barcelona, Spain.
Estefanía MorenoDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona, University of Barcelona, Barcelona, Spain.
Fernando López-ArmentaIntegrative Pharmacology and Systems Neuroscience, IMIM-Hospital del Mar Research Institute, Barcelona, Spain.
Daniel GuinartNeuropsychiatry and Addictions Institute (INAD) of Parc de Salut Mar, Centro de Investigación Biomédica En Red de Salud Mental G21, Mental Health Research Group, IMIM-Hospital del Mar Research Institute, Barcelona, Spain.
Aida Cuenca-RoyoIntegrative Pharmacology and Systems Neuroscience, IMIM-Hospital del Mar Research Institute, Barcelona, Spain.
Mercè Izquierdo-SerraLaboratory of Molecular Physiology, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.
Laura XicotaIntegrative Pharmacology and Systems Neuroscience, IMIM-Hospital del Mar Research Institute, Barcelona, Spain.
Cristina FernandezIntegrative Pharmacology and Systems Neuroscience, IMIM-Hospital del Mar Research Institute, Barcelona, Spain.
Esther MenoyoIntegrative Pharmacology and Systems Neuroscience, IMIM-Hospital del Mar Research Institute, Barcelona, Spain.
José M Fernández-FernándezLaboratory of Molecular Physiology, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.
Gloria Benítez-KingLaboratorio de Neurofarmacología, Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calzada México-Xochimilco 101 San Lorenzo Huipulco, Tlalpan, 14370, Mexico City, Mexico.
Enric I CanelaDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona, University of Barcelona, Barcelona, Spain.
Vicent CasadóDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona, University of Barcelona, Barcelona, Spain.
Víctor PérezNeuropsychiatry and Addictions Institute (INAD) of Parc de Salut Mar, Centro de Investigación Biomédica En Red de Salud Mental G21, Mental Health Research Group, IMIM-Hospital del Mar Research Institute, Barcelona, Spain.
Rafael de la TorreIntegrative Pharmacology and Systems Neuroscience, IMIM-Hospital del Mar Research Institute, Barcelona, Spain.
Patricia RobledoIntegrative Pharmacology and Systems Neuroscience, IMIM-Hospital del Mar Research Institute, Barcelona, Spain. probledo@imim.es.ORCID http://orcid.org/0000-0002-7941-0939
Hospital Del Mar · ESUniversitat Pompeu Fabra · ESInstituto de Salud Carlos III · ESInstituto Nacional de Psiquiatría Ramón de la Fuente Muñiz · MXParc de Salut · ESUniversitat Autònoma de Barcelona · ESUniversity of Cambridge · GB
Funding
Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya 2014-SGR-680 and 2014 SGR-1236Department of Experimental and Health Sciences MDM-2014-0370Instituto de Salud Carlos III P14/00210Ministerio de Economía y Competitividad SAF-2014-54840-RMinisterio de Economía y Competitividad SAF-2015-69762-R
Abstract
Cannabinoid CB1 receptors (CB
Indexed as
AdultBiomarkersCannabisCell LineageFemaleHumansMaleMemory, Short-TermNeuroepithelial CellsNeuronsNeuropsychological TestsOlfactory BulbReceptor, Cannabinoid, CB1Receptor, Serotonin, 5-HT2ASubstance-Related DisordersBiomarkersReceptor, Cannabinoid, CB1Receptor, Serotonin, 5-HT2ACannabisCB1R-5HT2AR heteromersCognitiveHuman olfactory neuroepitheliumProgenitor cells
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.